Companies Cryptocurrencies
Castle Biosciences Inc
Castle Biosciences Inc
Exchange: NasdaqGM
IPO Date: 25/07/2019
CEO: Mr. Derek Maetzold
Diagnostics & Research Healthcare 🔗
  • CSTL
  • 63.58
  • 1600143360
    market cap
  • -1.5199966
If you bought

shares of Castle Biosciences Inc (CSTL) on
You would have made
Old Price $12 Current Price $12

Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The company is headquartered in Friendswood, Texas and currently employs 94 full-time employees. The firm is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The firm has two market proprietary products, DecisionDx-Melanoma and DecisionDx-UM, and have two active proprietary products in development DecisionDx-UM and DecisionDx-Melanoma. The firm is developing a treatment plan for certain cancers using clinical and pathology factors. Its lead product, DecisionDx-Melanoma, is a proprietary multi-gene expression profile (GEP), a test that predicts the risk of metastasis or recurrence for patients diagnosed with invasive cutaneous melanoma, a deadly skin cancer.

Address: 820 S Friendswood Dr Ste 201 Friendswood TEXAS 77546

Stay updated.